204. Deputy David Cullinane asked the Minister for Health the number of medicines which entered the HSE reimbursement process in each year 2021 to 2025 and to date in 2026; the number which received a final reimbursement decision; the average, median and longest time spent at each stage from reimbursement application and pharmacoeconomic assessment to final decision; the number and duration of clock stops; the number and percentage completed within the applicable administrative or process target; and the equivalent figures separately for orphan medicines, medicines for rare diseases, oncology medicines and all other medicines, in tabular form. [67623/26]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.